Medical Health Cluster

Ingles

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

Question  Among individuals who had symptomatic SARS-CoV-2 infection in 2020 and 2021, what proportion experienced common self-reported Long COVID symptom clusters 3 months after initial infection? Findings  This observational analysis involved bayesian meta-regression and pooling of 54 studies and 2 medical record databases with data for 1.2 million individuals (from 22 countries) […]

Read More

COVID Rebound After Pfizer Treatment Likely Due to Robust Immune Response, Study Finds

A rebound of COVID-19 symptoms in some patients after taking Pfizer’s antiviral Paxlovid may be related to a robust immune response rather than a weak one, U.S. government researchers reported on Thursday. They concluded that taking a longer course of the drug – beyond the recommended five days – was […]

Read More

More than 30 million urged to take flu and COVID vaccines to stave off potential ‘twindemic’

A potentially fatal strain of flu currently in circulation worldwide could be more of a threat to public health than COVID this winter, a senior government health adviser has warned. Dr Susan Hopkins, chief medical adviser at UK Health Security Agency (UKHSA) warned that COVID will still present a major challenge for […]

Read More

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus Betacoronavirus. The ancestor strain has evolved into a number of variants of concern, with the Omicron variant of concern now having many distinct sublineages. The ongoing COVID-19 […]

Read More

FDA releases important information about risk of COVID-19 due to certain variants not neutralized by Evusheld

FDA added important information to the authorized Fact Sheets for Evusheld (tixagevimab co-packaged with cilgavimab) to inform health care providers and individuals receiving Evusheld of the increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are not neutralized by Evusheld. Detailed neutralization data can be found in […]

Read More

Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022

Summary What is already known about this topic? COVID-19 vaccines have been effective in preventing SARS-CoV-2 infection and associated hospitalizations and deaths among nursing home residents. What is added by this report? In a large cohort of nursing home residents, receipt of a second mRNA COVID-19 booster dose during circulation […]

Read More

What is Sepsis?

Anyone can get an infection, and almost any infection, including COVID-19, can lead to sepsis. In a typical year: At least 1.7 million adults in America develop sepsis. At least 350,000 adults who develop sepsis die during their hospitalization or are discharged to hospice. 1 in 3 people who dies in a hospital had sepsis […]

Read More